In recent years, a series of wide-ranging reforms designed to make greater use of market mechanisms has
succeeded in eliminating shortages, raising efficiency and improving citizen satisfaction. Nevertheless, spending
accelerated after the reforms, and per capita spending on health is now one of the highest in the OECD.
Centralisation of hospital ownership may have increased political influence, encouraging spending that cannot
be justified on cost-benefit grounds. Co-payments by patients are modest, and the background of swelling oil
wealth may have sapped willingness to control costs. Diagnosis related group (DRG) procedures are arguably
too well-remunerated in some areas, leading to supply-driven interventions, while their absence in others (e.g.
psychiatry) may have resulted in sub-optimal supply. Generalist doctors have a gatekeeper role, but are said to
over-refer patients to hospitals. Although cost controlling mechanisms exist in Norway, they are too often
sidestepped by pressure by citizens on politicians to approve new drugs and treatments. Thus, future health
reforms in Norway should concentrate on value for money.
This paper relates to the 2005 OECD Economic Survey of Norway (www.oecd.org/eco/survey/norway).
Balancing Health Care Quality and Cost Containment
The Case of Norway
Working paper
OECD Economics Department Working Papers
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Working paper20 September 2024
-
5 September 2024
-
5 September 2024
Related publications
-
30 July 2024
-
Country note10 July 2024